ArticleBiotech (Basel (Switzerland))2025
Comparing Handcrafted Radiomics Versus Latent Deep Learning Features of Admission Head CT for Hemorrhagic Stroke Outcome Prediction.
Article in Biotech (Basel (Switzerland)), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Radiomic prediction of early progression at 2 years post-treatment in patients with resectable rectal cancer based on rectal tumor and mesentery characteristics: a two-center study.Journal of gastrointestinal oncology · 2026Article
- A stacking model for AI-assisted diagnosis of suspected pituitary microadenomas on non-contrast T1COR MRI: a multicenter reader study on bridging the experience gap.Neuroradiology · 2026Article
- Development and internal validation of a high-resolution computed tomography radiomics and three-dimensional deep learning diagnostic prediction model for preoperative differentiation of minimally invasive and invasive adenocarcinoma in subsolid nodules.Journal of thoracic disease · 2026Article
- Hybrid Metaheuristic Feature Selection for Breast Cancer Detection in Digital Mammography: A Feasibility Study with Nested Validation, Benchmarking, and External Stress Testing.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Handcrafted radiomics use predefined formulas to extract quantitative features from medical images, whereas deep neural networks learn de novo features through iterative training. We compared these approaches for predicting 3-month outcomes and hematoma expansion from admission non-contrast head CT in acute intracerebral hemorrhage (ICH). Training and cross-validation were performed using a multicenter trial cohort (n = 866), with external validation on a single-center dataset (n = 645). We trained multiscale U-shaped segmentation models for hematoma segmentation and extracted (i) radiomics from the segmented lesions and (ii) two latent deep feature sets-from the segmentation encoder and a generative autoencoder trained on dilated lesion patches. Features were reduced with unsupervised Non-Negative Matrix Factorization (NMF) to 128 per set and used-alone or in combination-for six machine-learning classifiers to predict 3-month clinical outcomes and (>3, >6, >9 mL) hematoma expansion thresholds. The addition of latent deep features to radiomics numerically increased model prediction performance for 3-month outcomes and hematoma expansion using Random Forest, XGBoost, Extra Trees, or Elastic Net classifiers; however, the improved accuracy only reached statistical significance in predicting >3 mL hematoma expansion. Clinically, these consistent but modest increases in prediction performance may improve risk stratification at the individual level. Nevertheless, the latent deep features show potential for extracting additional clinically relevant information from admission head CT for prognostication in hemorrhagic stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.